Skip to main content
Top
Published in: Clinical and Experimental Medicine 4/2009

01-12-2009 | Original Article

MTHFR (methylenetetrahydrofolate reductase) C677T polymorphism and psoriasis

Authors: Vladimir Vasku, Julie Bienertova-Vasku, Miroslav Necas, Anna Vasku

Published in: Clinical and Experimental Medicine | Issue 4/2009

Login to get access

Abstract

The aim of the study was to evaluate possible association of MTHFR C677T gene polymorphism (NM_005957) with psoriasis. Genotypes of MTHFR C677T gene polymorphism were determined in a sample of 654 Caucasian (Czech) subjects. Case group (n = 410) included patients with psoriasis (plaque psoriasis diagnosed in 285 patients, other subtypes of psoriasis were observed in 125 patients). Control group (n = 244) consisted of healthy subjects without individual history of psoriasis, with similar age and gender characteristics. The MTHFR C677T polymorphism genotypes were determined by a polymerase chain reaction and a subsequent restriction analysis with HinfI. The genotypes of C(677)T methylenetetrahydrofolate reductase (MTHFR) gene polymorphism were determined in a sample of 654 Caucasian (Czech) subjects. We proved a significant difference in genotype distribution (P g = 0.03) and allelic frequency (P a = 0.02) between psoriatic and control subjects (Table 3). The CC (the thermostabile) genotype was significantly more frequent in psoriatic patients compared to controls [OR = 1.55, 95% confidential interval (CI) = 1.12–2.15, P = 0.004814, P corr = 0.01]. But, a significant increase of T allele in MTHFR gene was observed in patients with positive family history of diabetes (P a = 0.02) and in those with a frequent tonsillitis/tonsillectomy (P a = 0.04). No difference was observed between patients with and without positive family history of psoriasis (P a = 0.251). But, when psoriatic patients were described for FHDM, FH-Ps, and PH-T simultaneously, The highest incidence of CT + TT genotypes was calculated for psoriasis patients with positive history of psoriasis and diabetes mellitus together with personal history of repeated tonsillitis/tonsillectomy compared to patients without all these three phenotypes (odds ratio = 3.17, 95% CI 1.33–7.56, P corr = 0.04). In conclusion, MTHFR C677T polymorphism is marginally associated with psoriasis. The T allele (thermolabile) appears to be more frequent in psoriasis patients with positive history of psoriasis and diabetes mellitus together with personal history of repeated tonsillitis/tonsillectomy. This could reflect an inborn predisposition in complex regulation in one-carbon moieties transport in psoriatic patients and therefore, MTHFR genotype can be a part of genetic background of psoriasis.
Literature
1.
go back to reference Refsum H, Helland S, Ueland PM (1989) Fasting plasma homocysteine as a sensitive parameter of antifolate effect: a study of psoriasis patients receiving low-dose methotrexate treatment. Clin Pharmacol Ther 46(5):510–520PubMed Refsum H, Helland S, Ueland PM (1989) Fasting plasma homocysteine as a sensitive parameter of antifolate effect: a study of psoriasis patients receiving low-dose methotrexate treatment. Clin Pharmacol Ther 46(5):510–520PubMed
2.
go back to reference Prystowsky JH, Orologa A, Taylor S (1993) Update on nutrition and psoriasis. Int J Dermatol 32(8):582–586PubMedCrossRef Prystowsky JH, Orologa A, Taylor S (1993) Update on nutrition and psoriasis. Int J Dermatol 32(8):582–586PubMedCrossRef
3.
go back to reference Matherly LH (2001) Molecular and cellular biology of the human reduced folate carrier. Prog Nucleic Acid Res Mol Biol 67:131–162PubMedCrossRef Matherly LH (2001) Molecular and cellular biology of the human reduced folate carrier. Prog Nucleic Acid Res Mol Biol 67:131–162PubMedCrossRef
4.
go back to reference Gisondi P, Fantuzzi F, Malerba M et al (2007) Folic acid in general medicine and dermatology. J Dermatolog Treat 18(3):138–146PubMedCrossRef Gisondi P, Fantuzzi F, Malerba M et al (2007) Folic acid in general medicine and dermatology. J Dermatolog Treat 18(3):138–146PubMedCrossRef
5.
go back to reference Malerba M, Gisondi P, Radaeli A et al (2006) Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. Br J Dermatol 155(6):1165–1169PubMedCrossRef Malerba M, Gisondi P, Radaeli A et al (2006) Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. Br J Dermatol 155(6):1165–1169PubMedCrossRef
6.
go back to reference Vanizor Kural B, Orem A, Cimsit G et al (2003) Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients. Clin Chim Acta 332(1–2):23–30PubMedCrossRef Vanizor Kural B, Orem A, Cimsit G et al (2003) Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients. Clin Chim Acta 332(1–2):23–30PubMedCrossRef
7.
go back to reference Friso S, Choi SW (2002) Gene-nutrient interactions and DNA methylation. J Nutr 132(8 Suppl):2382S–2387SPubMed Friso S, Choi SW (2002) Gene-nutrient interactions and DNA methylation. J Nutr 132(8 Suppl):2382S–2387SPubMed
8.
go back to reference Friso S, Choi SW, Girelli D et al (2002) A common mutation in the 5, 10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 99(8):5606–5611PubMedCrossRef Friso S, Choi SW, Girelli D et al (2002) A common mutation in the 5, 10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 99(8):5606–5611PubMedCrossRef
9.
go back to reference Mee JB, Johnson CM, Morar N et al (2007) The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis. Am J Pathol 171(1):32–42PubMedCrossRef Mee JB, Johnson CM, Morar N et al (2007) The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis. Am J Pathol 171(1):32–42PubMedCrossRef
10.
go back to reference Zhang K, Zhang R, Li X et al (2007) The mRNA expression and promoter methylation status of the p16 gene in colony-forming cells with high proliferative potential in patients with psoriasis. Clin Exp Dermatol 32(6):702–708PubMedCrossRef Zhang K, Zhang R, Li X et al (2007) The mRNA expression and promoter methylation status of the p16 gene in colony-forming cells with high proliferative potential in patients with psoriasis. Clin Exp Dermatol 32(6):702–708PubMedCrossRef
11.
go back to reference Ruchusatsawat K, Wongpiyabovorn J, Shuangshoti S et al (2006) SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis. J Mol Med 84(2):175–182PubMedCrossRef Ruchusatsawat K, Wongpiyabovorn J, Shuangshoti S et al (2006) SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis. J Mol Med 84(2):175–182PubMedCrossRef
12.
go back to reference Frost P et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–113CrossRef Frost P et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–113CrossRef
13.
go back to reference Wilcken B, Bamforth F, Li Z et al (2003) Geographical and ethnic variation of the 677C>T allele of 5, 10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet 40(8):619–625PubMedCrossRef Wilcken B, Bamforth F, Li Z et al (2003) Geographical and ethnic variation of the 677C>T allele of 5, 10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet 40(8):619–625PubMedCrossRef
14.
go back to reference Baiqiu W, Songbin F, Guiyin Z et al (2000) Study of the relationship between psoriasis and the polymorphic site C677T of methylenetetrahydrofolate reductase. Chin Med Sci J 15(2):119–120PubMed Baiqiu W, Songbin F, Guiyin Z et al (2000) Study of the relationship between psoriasis and the polymorphic site C677T of methylenetetrahydrofolate reductase. Chin Med Sci J 15(2):119–120PubMed
15.
go back to reference Weger W, Hofer A, Stanger O et al (2008) The methylenetetrahydrofolate reductase 677C>T gene polymorphism is not associated with chronic plaque psoriasis. Exp Dermatol 17(9):748–751PubMedCrossRef Weger W, Hofer A, Stanger O et al (2008) The methylenetetrahydrofolate reductase 677C>T gene polymorphism is not associated with chronic plaque psoriasis. Exp Dermatol 17(9):748–751PubMedCrossRef
16.
go back to reference Han J, Colditz GA, Hunter DJ (2007) Polymorphisms in the MTHFR and VDR genes and skin cancer risk. Carcinogenesis 28(2):390–397PubMedCrossRef Han J, Colditz GA, Hunter DJ (2007) Polymorphisms in the MTHFR and VDR genes and skin cancer risk. Carcinogenesis 28(2):390–397PubMedCrossRef
17.
go back to reference Festa F, Kumar R, Sanyal S et al (2005) Basal cell carcinoma and variants in genes coding for immune response, DNA repair, folate and iron metabolism. Mutat Res 574(1–2):105–111PubMed Festa F, Kumar R, Sanyal S et al (2005) Basal cell carcinoma and variants in genes coding for immune response, DNA repair, folate and iron metabolism. Mutat Res 574(1–2):105–111PubMed
18.
go back to reference Zhang Z, Liu W, Jia X et al (2004) Use of pyrosequencing to detect clinically relevant polymorphisms of genes in basal cell carcinoma. Clin Chim Acta 342(1–2):137–143PubMedCrossRef Zhang Z, Liu W, Jia X et al (2004) Use of pyrosequencing to detect clinically relevant polymorphisms of genes in basal cell carcinoma. Clin Chim Acta 342(1–2):137–143PubMedCrossRef
19.
go back to reference Martin-Subero JI, Bibikova M, Mackay D et al (2008) Microarray-based DNA methylation analysis of imprinted loci in a patient with transient neonatal diabetes mellitus. Am J Med Genet A 146A(24):3227–3229PubMedCrossRef Martin-Subero JI, Bibikova M, Mackay D et al (2008) Microarray-based DNA methylation analysis of imprinted loci in a patient with transient neonatal diabetes mellitus. Am J Med Genet A 146A(24):3227–3229PubMedCrossRef
Metadata
Title
MTHFR (methylenetetrahydrofolate reductase) C677T polymorphism and psoriasis
Authors
Vladimir Vasku
Julie Bienertova-Vasku
Miroslav Necas
Anna Vasku
Publication date
01-12-2009
Publisher
Springer Milan
Published in
Clinical and Experimental Medicine / Issue 4/2009
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-009-0054-0

Other articles of this Issue 4/2009

Clinical and Experimental Medicine 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.